[{"type": "title", "data": "CARD STEMI Post Fibrinolytic Therapy - Ongoing Management (Module)"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Ensure inital doses of antiplatelets have been administered", "value": ""}, {"type": "order", "data": "ASA EC", "value": "checked"}, {"type": "sentence", "data": "81 mg, PO, qdaily, drug form: tab-EC"}, {"type": "order", "data": "clopidogrel", "value": "checked"}, {"type": "sentence", "data": "75 mg, PO, qdaily, drug form: tab"}, {"type": "note", "data": "For patients 75 years or less", "value": ""}, {"type": "note", "data": "Select enoxaparin (preferred) or heparin (use CARD Heparin Infusion Post Fibrinolytic (Module))", "value": ""}, {"type": "note", "data": "Enoxaparin is CONTRAINDICATED if eGFR is less than 30 mL/min or if patient has known or suspected renal insufficiency", "value": ""}, {"type": "note", "data": "Ensure initial dose of anticoagulants have been administered", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, subcutaneous, q12h, order duration: 8 day, drug form: inj"}, {"type": "sentence", "data": "100 mg, subcutaneous, q12h, order duration: 8 day, drug form: inj"}, {"type": "note", "data": "For patients older than 75 years", "value": ""}, {"type": "note", "data": "Select fondaparinux (preferred) or heparin (use CARD Heparin Infusion Post Fibrinolytic (Module))", "value": ""}, {"type": "note", "data": "fondaparinux CONTRAINDICATED if eGFR is LESS than 30 mL/min; possibility of PCI in the next 7 days", "value": ""}, {"type": "order", "data": "fondaparinux", "value": ""}, {"type": "sentence", "data": "2.5 mg, subcutaneous, qPM, order duration: 7 day"}, {"type": "note", "data": "caRVEDILOl target dose: 25 mg PO BID", "value": ""}, {"type": "order", "data": "caRVEDILOl", "value": ""}, {"type": "sentence", "data": "3.125 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "6.25 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "12.5 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "25 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "50 mg, PO, BID, drug form: tab"}, {"type": "note", "data": "bisOPROLOL target dose: 10 mg PO Daily", "value": ""}, {"type": "order", "data": "bisOPROLOL", "value": ""}, {"type": "sentence", "data": "2.5 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "1.25 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "5 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "10 mg, PO, qdaily, drug form: tab"}, {"type": "note", "data": "metoprolol target dose: 100 mg PO BID", "value": ""}, {"type": "order", "data": "metoprolol", "value": ""}, {"type": "sentence", "data": "25 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "12.5 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "50 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "100 mg, PO, BID, drug form: tab"}, {"type": "note", "data": "Re-assess therapy if serum creatinine increases by more than 30% or if serum potassium rises above 5.2 mmol/L", "value": ""}, {"type": "order", "data": "ramipril", "value": ""}, {"type": "sentence", "data": "2.5 mg, PO, BID, drug form: cap"}, {"type": "sentence", "data": "1.25 mg, PO, BID, drug form: cap"}, {"type": "sentence", "data": "5 mg, PO, BID, drug form: cap"}, {"type": "sentence", "data": "2.5 mg, PO, qdaily, drug form: cap"}, {"type": "sentence", "data": "5 mg, PO, qdaily, drug form: cap"}, {"type": "sentence", "data": "10 mg, PO, qdaily, drug form: cap"}, {"type": "order", "data": "perindopril", "value": ""}, {"type": "sentence", "data": "4 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "2 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "8 mg, PO, qdaily, drug form: tab"}, {"type": "note", "data": "Avoid combination of ACE Inhibitor with ARB", "value": ""}, {"type": "note", "data": "Angiotensin Receptor Blocker (ARB) - indicated for ACE- inhibitor intolerance", "value": ""}, {"type": "note", "data": "Re-assess therapy if serum creatinine increases by more than 30% or if serum potassium rises above 5.2 mmol/L", "value": ""}, {"type": "order", "data": "candesartan", "value": ""}, {"type": "sentence", "data": "8 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "4 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "16 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "32 mg, PO, qdaily, drug form: tab"}, {"type": "order", "data": "valsartan", "value": ""}, {"type": "sentence", "data": "40 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "80 mg, PO, BID, drug form: tab"}, {"type": "sentence", "data": "160 mg, PO, BID, drug form: tab"}, {"type": "order", "data": "losartan", "value": ""}, {"type": "sentence", "data": "25 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "50 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "75 mg, PO, qdaily, drug form: tab"}, {"type": "sentence", "data": "100 mg, PO, qdaily, drug form: tab"}, {"type": "note", "data": "Avoid nitroglycerin if any of the following are present:   - SBP below 90 mmHg or if more than 30 mmHg drop from baseline  - Suspected right ventricular infarction  - Recent use of phosphodiesterase inhibitors; within 24 hours for sildenafil [VIAGRA] and vardenafil [LEVITRA]; within 48 hours for tadalafil [CIALIS]", "value": ""}, {"type": "order", "data": "nitroglycerin 0.4 mg/spray spray", "value": ""}, {"type": "sentence", "data": "1 spray, sublingual, q5min, PRN other (see comment), drug form: spray"}, {"type": "order", "data": "nitroglycerin titratable infusion (0.2 mg/mL) in D5W standard", "value": ""}, {"type": "sentence", "data": "Titrate, IV, 10 mcg/min starting rate, 0 mcg/min minimum rate, 200 mcg/min maximum rate, titrate instructions: Titrate by 10 mcg/min, q5min PRN for symptoms of ischemia; maintain SPB above 90 mmHg"}, {"type": "sentence", "data": "50 mg"}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "Conditional Order - One Time", "value": ""}, {"type": "sentence", "data": "If/when fibrinolytic therapy is given, then RN to place an order for Electrocardiogram 12 Lead 60 minutes post administration"}, {"type": "category", "data": "Communication Orders"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Ensure an evaluation of Left Ventricular function is acquired prior to discharge"}]
